- Home
- GL vs PEN Comparison
GL vs PEN Comparison
Compare GL & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GL
- PEN
- Stock Information
- Founded
- GL 1900
- PEN 2004
- Country
- GL United States
- PEN United States
- Employees
- GL N/A
- PEN N/A
- Industry
- GL Life Insurance
- PEN Medical/Dental Instruments
- Sector
- GL Finance
- PEN Health Care
- Exchange
- GL Nasdaq
- PEN Nasdaq
- Market Cap
- GL 10.2B
- PEN 10.9B
- IPO Year
- GL N/A
- PEN 2015
- Fundamental
- Price
- GL $121.86
- PEN $266.93
- Analyst Decision
- GL Buy
- PEN Strong Buy
- Analyst Count
- GL 11
- PEN 16
- Target Price
- GL $137.73
- PEN $299.73
- AVG Volume (30 Days)
- GL 626.7K
- PEN 554.0K
- Earning Date
- GL 07-23-2025
- PEN 07-29-2025
- Dividend Yield
- GL 0.89%
- PEN N/A
- EPS Growth
- GL 17.62
- PEN N/A
- EPS
- GL 12.31
- PEN 1.08
- Revenue
- GL $5,842,352,000.00
- PEN $1,240,100,000.00
- Revenue This Year
- GL $7.96
- PEN $14.60
- Revenue Next Year
- GL $5.35
- PEN $14.17
- P/E Ratio
- GL $9.90
- PEN $247.65
- Revenue Growth
- GL 5.41
- PEN 13.17
- 52 Week Low
- GL $76.55
- PEN $148.00
- 52 Week High
- GL $133.76
- PEN $310.00
- Technical
- Relative Strength Index (RSI)
- GL 51.46
- PEN 39.77
- Support Level
- GL $119.67
- PEN $260.38
- Resistance Level
- GL $123.03
- PEN $275.41
- Average True Range (ATR)
- GL 2.20
- PEN 9.23
- MACD
- GL 0.15
- PEN -2.51
- Stochastic Oscillator
- GL 64.35
- PEN 15.55
About GL Globe Life Inc.
Globe Life Inc is an insurance holding company. It provides a variety of life and supplemental health insurance products and annuities to a broad base of customers. The company's core operations are organized into three reportable segments: life insurance, supplemental health insurance and investments. Investment activities, conducted by the investment segment, focus on seeking investments with a yield and term appropriate to support the insurance product obligations. These investments generally consist of fixed maturities and, over the long term, the expected yields are considered when setting insurance premium rates and product profitability expectations.
About PEN Penumbra Inc.
Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. It operates as one reportable segment and its business activity consists of the design, development, manufacturing and marketing of inventive medical products.